Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine

被引：10

作者：

Kelly, DL ^{[1
]}

Kreyenbuhl, J ^{[1
]}

Love, RC ^{[1
]}

Van-Duong, Q ^{[1
]}

Conley, RR ^{[1
]}

机构：

[1] Univ Maryland, Baltimore, MD 21201 USA

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 09期

关键词：

D O I：

10.4088/JCP.v64n0921f

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：1133 / 1134

页数：2

共 50 条

[31] Olanzapine weight change and other metabolic parameters in cocaine abuse methadone patients
Baño, MD
López, ML
Muñoz, V
Guillén, JL
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S398 - S399
[32] Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study
Alvarez, Enric
Bernardo, Miguel
Gutierrez Casares, Jose Ramon
Montejo, Angel L.
EUROPEAN JOURNAL OF PSYCHIATRY, 2012, 26 (04): : 248 - 259
[33] Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial
Kelly, Deanna L.
Glassman, Matthew
Wonodi, Ikwunga
Vyas, Gopal
Richardson, Charles M.
Nwulia, Evaristus
Wehring, Heidi J.
Oduguwa, Taiwo
Mackowick, Marie
Hipolito, Maria Mananita S.
Peters, Olawunmi
Rai, Narayan
Park, Jaeboon
Adebayo, Adeola O.
Gorelick, David A.
Weiner, Elaine
Liu, Fang
Kearns, Ann Marie
Adams, Heather A.
Love, Raymond C.
Chen, Shuo
Olaniyan, Ayodeji
Ambulos, Nicholas
Mckoy, Darius
Nallani, Madhulika C.
Lanzkron, Sophie
Mengistab, Mulu
Barr, Brian
Davis, Erica
Lawal, Rahman
Buchanan, Robert W.
Adebayo, Richard
SCHIZOPHRENIA RESEARCH, 2024, 268 : 312 - 322
[34] Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine
Feng, Shelley
Melkersson, Kristina
NEUROENDOCRINOLOGY LETTERS, 2012, 33 (05) : 493 - 498
[35] Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol
Krakowski, Menahem
Czobor, Pal
Citrome, Leslie
SCHIZOPHRENIA RESEARCH, 2009, 110 (1-3) : 95 - 102
[36] Use of the sperm quality analyzer in uro-andrological patients: Review of a six-month experience
Ferrando, U
Pagliano, GL
Gramaglia, M
ANDROLOGY 1996 - TWENTY YEARS LATER: PROCEEDINGS OF THE TENTH NATIONAL CONGRESS OF THE SOCIETY OF ANDROLOGY, 1996, : 311 - 315
[37] Lack of Effect of Risperidone or Olanzapine Dose Reduction on Metabolic Parameters, Prolactin, and Corrected QT Interval in Stable Patients With Schizophrenia
Takeuchi, Hiroyoshi
Suzuki, Takefumi
Remington, Gary
Watanabe, Koichiro
Mimura, Masaru
Uchida, Hiroyuki
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 517 - 520
[38] Comparison of olanzapine and quetiapine antipsychotic treatments for schizophrenia: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
Boland, J
O'Halloran, RA
Dossenbach, M
Levitt, L
Enatescu, V
Simon, L
Janu, L
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 274
[39] A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
Newcomer, John W.
Ratner, Robert E.
Eriksson, Jan W.
Emsley, Robin
Meulien, Didier
Miller, Frank
Leonova-Edlund, Julia
Leong, Ronald W.
Brecher, Martin
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 487 - 499
[40] Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China
Zhou, Tianhang
Pu, Chengcheng
Huang, Zetao
Gao, Tianqi
Zhou, Enpeng
Zheng, Yue
Zhang, Dan
Huang, Bingjie
Cheng, Zhang
Shi, Chuan
Yu, Xin
ASIAN JOURNAL OF PSYCHIATRY, 2023, 84

← 1 2 3 4 5 →